Martine Rothblatt, PhD, JD
President and CEO
Lung Bioengineering was born from the difficult experiences of one PAH patient, our founder’s daughter.
When she was ten years old, she could barely walk to her school bus without becoming short of breath. Her doctors explained the prognosis of a typical PAH patient at that time.
Her mother refused to accept this outcome and instead began looking for solutions to her daughter’s condition. She was the first in an ever-expanding line of patients to inspire Lung Bioengineering to reach farther to develop novel therapies. People with PAH lead us to this path, and we forge ahead for them and others with chronic lung diseases.